PMC:7456455 / 33145-33333 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T407","span":{"begin":93,"end":104},"obj":"Body_part"}],"attributes":[{"id":"A407","pred":"fma_id","subj":"T407","obj":"http://purl.org/sig/ont/fma/fma63261"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T204","span":{"begin":119,"end":125},"obj":"Disease"}],"attributes":[{"id":"A204","pred":"mondo_id","subj":"T204","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T459","span":{"begin":6,"end":7},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T171","span":{"begin":0,"end":2},"obj":"Chemical"}],"attributes":[{"id":"A171","pred":"chebi_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/CHEBI_74814"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-sentences","denotations":[{"id":"T207","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T208","span":{"begin":141,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":75,"end":81},"obj":"Phenotype"},{"id":"T48","span":{"begin":119,"end":125},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A48","pred":"hp_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T851","span":{"begin":37,"end":44},"obj":"CL:0000763"},{"id":"T852","span":{"begin":93,"end":104},"obj":"CL:0000235"},{"id":"T32654","span":{"begin":93,"end":104},"obj":"CL:0000235"},{"id":"T55177","span":{"begin":37,"end":44},"obj":"CL:0000763"},{"id":"T10700","span":{"begin":93,"end":104},"obj":"CL:0000235"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}

{"project":"LitCovid-PubTator","denotations":[{"id":"736","span":{"begin":22,"end":29},"obj":"Chemical"},{"id":"737","span":{"begin":119,"end":125},"obj":"Disease"}],"attributes":[{"id":"A737","pred":"tao:has_database_id","subj":"737","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"SG is a consultant to Verseau and to Myeloid Therapeutics, both exploiting Tumour associated macrophages for potential cancer immunotherapy. Other authors declare no conflicts of interest."}